These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2896890)

  • 1. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
    Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
    Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
    Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
    Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
    [No Abstract]   [Full Text] [Related]  

  • 4. Foscarnet for cytomegalovirus retinitis.
    Singer DR; Fallon TJ; Schulenburg WE; Williams G; Cohen J
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):962. PubMed ID: 2998255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy and immunoprophylaxis of HIV infection].
    Vogt M; Schooley RT; Hirsch MS
    Schweiz Rundsch Med Prax; 1986 Nov; 75(48):1471-5. PubMed ID: 2432642
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    Walmsley SL; Chew E; Read SE; Vellend H; Salit I; Rachlis A; Fanning MM
    J Infect Dis; 1988 Mar; 157(3):569-72. PubMed ID: 2830347
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of cytomegalovirus infections in immunosuppressed patients].
    Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
    Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
    [No Abstract]   [Full Text] [Related]  

  • 9. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
    Jackson GG; Paul DA; Falk LA; Rubenis M; Despotes JC; Mack D; Knigge M; Emeson EE
    Ann Intern Med; 1988 Feb; 108(2):175-80. PubMed ID: 3124680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
    Farthing C; Anderson MG; Ellis ME; Gazzard BG; Chanas AC
    J Med Virol; 1987 Jun; 22(2):157-62. PubMed ID: 3039052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
    Gaub J; Pedersen C; Poulsen AG; Mathiesen LR; Ulrich K; Lindhardt BO; Faber V; Gerstoft J; Hofmann B; Lernestedt JO
    AIDS; 1987 May; 1(1):27-33. PubMed ID: 2962590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foscarnet for cytomegalovirus infections.
    Ringdén O; Wilczek H; Lönnqvist B; Gahrton G; Wahren B; Lernestedt JO
    Lancet; 1985 Jun; 1(8444):1503-4. PubMed ID: 2861426
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053).
    Jacobsen MA; van der Horst C; Causey DM; Dehlinger M; Hafner R; Mills J
    J Infect Dis; 1991 Jun; 163(6):1219-22. PubMed ID: 1828075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
    Jacobson MA; Mills J; Rush J; O'Donnell JJ; Miller RG; Greco C; Gonzales MF
    Arch Neurol; 1988 Oct; 45(10):1090-2. PubMed ID: 2845899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foscarnet in fulminant hepatitis B.
    Price JS; France AJ; Moaven LD; Welsby PD
    Lancet; 1986 Nov; 2(8518):1273. PubMed ID: 2878146
    [No Abstract]   [Full Text] [Related]  

  • 16. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A
    Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential of phosphonoformate for the treatment of herpex simplex labialis.
    Oxford J
    J Antimicrob Chemother; 1980 Nov; 6(6):694-5. PubMed ID: 6449499
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

  • 20. Foscarnet and extended survival in AIDS patients.
    Am Fam Physician; 1991 Dec; 44(6):2244. PubMed ID: 1836090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.